Activation of the VEGFR1 chromatin domain -: An angiogenic signal-ETS1/HIF-2α regulatory axis

被引:47
作者
Dutta, Debasree
Ray, Soma
Vivian, Jay L.
Paul, Soumen [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1074/jbc.M804349200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Angiogenesis is induced by multiple growth factors including vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2). In vascular endothelium VEGF signals through two receptor-tyrosine kinases, VEGFR1 and VEGFR2. The VEGFR1 gene encodes both a receptor-tyrosine kinase and a secreted splice variant, soluble VEGFR1. Whereas VEGFR1 is essential for vascular development, mechanisms that regulate VEGFR1 expression in endothelial cells are poorly understood. We demonstrate here that in endothelial cells, FGF2 and epidermal growth factor (EGF) signaling induce VEGFR1 mRNA expression in a combinatorial fashion. EGF/FGF2-mediated VEGFR1 induction is mediated via functional interaction of transcription factors ETS1 and HIF-2 alpha. Mechanistic analyses revealed that in endothelial cells EGF/FGF2 signaling induces ETS1 expression, increases HIF-2 alpha protein level in absence of hypoxia, and recruits both ETS1 and HIF-2 alpha to the VEGFR1 chromatin domain. Knockdown of ETS1 and HIF-2 alpha by RNA interference inhibits EGF/FGF2-induced VEGFR1 expression, and loss of expression is associated with impaired RNA-polymerase II recruitment and histone modifications at the VEGFR1 promoter region. In addition, using a mouse embryonic stem cell in vitro differentiation system, we found that induction of VEGFR1 in embryoid bodies is also associated with ETS1 and HIF-2 alpha recruitment to the VEGFR1 locus. These results establish an angiogenic signal-ETS1/HIF-2 alpha axis that regulates the VEGFR1 chromatin domain to induce VEGFR1 transcription in endothelial cells and in differentiating embryonic stem cells.
引用
收藏
页码:25404 / 25413
页数:10
相关论文
共 61 条
[1]
Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection [J].
Aprelikova, Olga ;
Wood, Matthew ;
Tackett, Sean ;
Chandramouli, Gadisetti V. R. ;
Barrett, J. Carl .
CANCER RESEARCH, 2006, 66 (11) :5641-5647
[2]
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[3]
Barleon B, 1997, CANCER RES, V57, P5421
[4]
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[5]
INCREASED T-CELL APOPTOSIS AND TERMINAL B-CELL DIFFERENTIATION-INDUCED BY INACTIVATION OF THE ETS-1 PROTOONCOGENE [J].
BORIES, JC ;
WILLERFORD, DM ;
GREVIN, D ;
DAVIDSON, L ;
CAMUS, A ;
MARTIN, P ;
STEHELIN, D ;
ALT, FW .
NATURE, 1995, 377 (6550) :635-638
[6]
Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-β stimulation [J].
Botella, LM ;
Sánchez-Elsner, T ;
Rius, C ;
Corbí, A ;
Bernabéu, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34486-34494
[7]
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[8]
Cox CM, 2000, DEV DYNAM, V218, P371, DOI 10.1002/(SICI)1097-0177(200006)218:2<371::AID-DVDY10>3.3.CO
[9]
2-Q
[10]
Cuenda A, 2000, METH MOL B, V99, P161